Latest Views & News

Optibiotix – er should you not have declared this related party deal with your chairman?

By Tom Winnifrith, The Sheriff of AIM | Wednesday 24 April 2019


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Optibiotix (OPTI) has announced the launch of SlimBiome® Medical in the UK – as of 29 April.  All; well and good and I remain an enthusiast for the shares - they are cheap. But there is another matter which is not so impressive in a word where transparency is now universally viewed as critical.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Tuesday »

SNX

Synectics – a recovery Buy?

 

GetAFix

Malcolm Stacey is Moving House

Monday »

WG

Wood Group - a Buy (again)?

 

Bear

Video: Bubbles always implode